A comparison of flufenamic acid and phenylbutazone in osteoarthritis of the hip.
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D001799:Blood Sedimentation; D001835:Body Weight; D002986:Clinical Trials as Topic; D005260:Female; D005439:Flufenamic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D005461:Fluorine / Q000627:therapeutic use; D006452:Hemoglobinometry; D006621:Hip Joint; D006801:Humans; D008297:Male; D008875:Middle Aged; D010003:Osteoarthritis / Q000188:drug therapy* / Q000503:physiopathology; D010146:Pain; D010653:Phenylbutazone / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D014508:Urea / Q000097:blood; D062367:ortho-Aminobenzoates / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D062367:ortho-Aminobenzoates; D005461:Fluorine; D005439:Flufenamic Acid; D014508:Urea; D010653:Phenylbutazone; D001241:Aspirin